Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Bawei Medicine Development & Research Institute is a specialized Contract Research Organization (CRO) based in the Suzhou Industrial Park, China. Founded in 2006, the company provides comprehensive bioanalytical and drug metabolism and pharmacokinetics (DMPK) services to support both pre-clinical and clinical drug development. Their facilities are GLP-compliant, offering expertise in method development, validation, and high-throughput sample analysis for small molecules, biologics, and biomarkers. The institute serves a global clientele, helping pharmaceutical and biotech companies navigate regulatory requirements for IND and NDA submissions. By leveraging advanced technologies like LC-MS/MS and ligand binding assays, Suzhou Bawei has established itself as a critical partner in the regional life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Bawei Medicine Development & Research Institute.